Chenming Zeng
Impact in
- Aging top 10%
- Cell Biology top 10%
- Aldose Reductase and Taurine
- Hippo pathway signaling and YAP/TAZ
Papers in
-
- CRISPR and Genetic Engineering 5
- RNA Research and Splicing 3
- Ubiquitin and proteasome pathways 3
- Heme Oxygenase-1 and Carbon Monoxide 2
-
- Aldose Reductase and Taurine 5
- Co-authors
- Hong Zhu (12 shared papers)Qiaojun He (14 shared papers)Bo Yang (12 shared papers)Meidan Ying (5 shared papers)Ji Cao (5 shared papers)Linlin Chang (4 shared papers)Chenxi Zhao (4 shared papers)Xiaoyang Dai (5 shared papers)
- Journals
- Nature Communications (4 papers)Acta Pharmacologica Sinica (3 papers)Theranostics (2 papers)Frontiers in Pharmacology (2 papers)Acta Pharmaceutica Sinica B (1 paper)
- Partner nations
- ChinaUnited KingdomMacao
In The Last Decade
Chenming Zeng
22 papers receiving 438 citations
Peers
Comparison fields: 5 of 69
- Aging 32
- Cell Biology 128
- Cancer Research 77
- Molecular Biology 304
- Geriatrics and Gerontology 13
Countries citing papers authored by Chenming Zeng
This map shows the geographic impact of Chenming Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenming Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenming Zeng more than expected).
Fields of papers citing papers by Chenming Zeng
This network shows the impact of papers produced by Chenming Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenming Zeng. The network helps show where Chenming Zeng may publish in the future.
Co-authors
The 25 scholars most cited alongside Chenming Zeng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 103 | |
| 2 | 2017 | 71 | |
| 3 | 2019 | 36 | |
| 4 | 2018 | 34 | |
| 5 | 2018 | 31 | |
| 6 | 2019 | 24 | |
| 7 | 2020 | 24 | |
| 8 | 2020 | 16 | |
| 9 | 2024 | 15 | |
| 10 | 2020 | 15 | |
| 11 | 2021 | 14 | |
| 12 | 2019 | 13 | |
| 13 | 2021 | 11 | |
| 14 | 2024 | 9 | |
| 15 | 2021 | 8 | |
| 16 | 2023 | 7 | |
| 17 | 2024 | 2 | |
| 18 | 2025 | 2 | |
| 19 | 2021 | 2 | |
| 20 | 2024 | 1 |
About Chenming Zeng
Chenming Zeng is a scholar working on Molecular Biology, Cell Biology, Plant Science, Aging and Cancer Research, having authored 22 papers that have together received 440 indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (5 papers), Aldose Reductase and Taurine (5 papers), Chromosomal and Genetic Variations (4 papers), Genetics, Aging, and Longevity in Model Organisms (4 papers), RNA Research and Splicing (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Ubiquitin and proteasome pathways (3 papers) and Heme Oxygenase-1 and Carbon Monoxide (2 papers). The work is most often cited by research in Aging (32 citations), Cell Biology (128 citations), Cancer Research (77 citations), Molecular Biology (304 citations) and Geriatrics and Gerontology (13 citations). Chenming Zeng has collaborated with scholars based in China, United Kingdom and Macao. Frequent co-authors include Hong Zhu, Qiaojun He, Bo Yang, Meidan Ying, Ji Cao, Linlin Chang, Chenxi Zhao, Xiaoyang Dai, Fangjie Yan and Tao Yuan. Their work appears in journals such as Nature Communications, Acta Pharmacologica Sinica, Theranostics, Frontiers in Pharmacology and Acta Pharmaceutica Sinica B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.